Table 2.
Applied tissue | Animal model | Defect | Dosage | Materials | Pretreatment | Outcome | Possible repair mechanisms | Ref. |
---|---|---|---|---|---|---|---|---|
Skin | New Zealand white rabbit | Full-thickness skin defects, 2 cm × 2 cm | 2 × 104 USCs/24-well plate-sized membranes | Polycaprolactone/gelatin nanofibrous (PCL/GT) membranes | N/A | Faster wound closure, increased re-epithelialization, collagen formation, and angiogenesis | USCs secrete VEGF and TGF-β1 promoting angiogenesis | [47] |
Skin | BALB/C nude mouse | Full-thickness skin defect, 10 mm in diameter | 1 × 106 USCs/100 μL PBS (subcutaneous injection) | N/A | Treated by diluted bioglass ionic (BG) extracts | Better wound healing ability, improved angiogenesis, more collagen deposition, and the collagen structure is closer to that in the mouse | BG ionic extracts activate the paracrine effects (VEGF-KDR) between USCs and recipient cells (endothelial cells and fibroblasts) in wound healing | [80] |
Skin | Streptozotocin-induced diabetic C57BL/6 mouse | Full-thickness skin defect, 6 mm in diameter | 200 μg USCs-Exos/100 μL PBS (intraperitoneal injection) | N/A | N/A | Accelerated wound healing, higher rates of re-epithelialization, more collagen deposition, improved cell (keratinocytes, fibroblasts and vascular endothelial) proliferation, less scar formation and improved angiogenesis | Exosomes (Exos) from USCs could effectively enhance the proliferation, migration and tube formation of vascular endothelial, promoting angiogenesis via transferring DMBT1 protein | [61] |
Skin | Sprague–Dawley rats | Full-thickness skin defect, 2 cm in diameter | 5 × 103 USCs/96-well plate-sized membranes | Surface-structured bacterial cellulose nanofiber (S-BC) membranes | N/A | Accelerated wound healing, faster re-epithelialization, more collagen production and neovascularization | The substance secreted from USCs and the effect of S-BC on the adhesion and proliferation of vascular endothelial cells promote angiogenesis | [81] |
Skin | BALB/C nude mouse | Full-thickness skin defect, 8 mm in diameter | 1 × 106 USCs/SIS membrane (10 mm in diameter) | Porcine small intestine submucosa (SIS) | The composites were pretreated with hypoxia (1% O2) for 24 h | Accelerated neovascularization, facilitated re-epithelialization, promoted skin appendage regeneration, improved the quality of collagen deposition and enhanced the wound healing | Hypoxic preconditioning enhanced composites secreting a large amount of growth factors (VEGF, EGF and bFGF) for enhancing wound angiogenesis at the early stage of wound healing | [82] |
Bone | N/A | N/A | USCs | N/A | Fresh medium containing 4 μg/mL silver nanoparticles (AgNPs) treated for 24 h | Promoted osteogenic differentiation of USCs | The AgNPs themselves, rather than the released silver ions, lead USCs into osteogenic differentiation via activating RhoA, inducing actin polymerization and increasing cytoskeletal tension | [98] |
Bone | Nude mouse | Ectopic bone formation (muscle pockets in hindlimbs) | 5 × 105 USCs/scaffold (5 × 5 × 3 mm) | Poly (lactic-co-glycolic acid)/calcium silicate composite (PLGA/CS) porous scaffold | One week culture in vitro | Induced osteogenic differentiation, ingrowth of blood vessels into scaffolds | CS induces the osteogenic differentiation of USCs through the Wnt/β-catenin signaling pathway | [44] |
Bone | Sprague–Dawley rats | 6 mm critically sized femoral defect | 5 × 105 USCs/scaffold (5 × 5 × 6 mm) | β-TCP porous scaffold | Composites cultured in osteogenic differentiation media for 7 days | Increased new osseous formation, 5 out of 11 transplants completely bridged the critical-size bone defect | USCs can adhere, proliferate and differentiate into osteoblasts on a β-TCP scaffold | [45] |
Bone | Nude mouse | Ectopic bone formation (muscle pockets in hindlimbs) | USCs (concentration not mentioned) | Porous ceramic scaffold made of β-tricalcium phosphate (β -TCP) | Lentiviral vectors-bone morphogenetic protein 2 (BMP2) gene transduction | Increased osteogenic activity of USCs, these transfected cells can undergo osteogenic differentiation without osteogenic medium in vitro, observed ectopic bone formation, USCs differentiate into osteoblasts | BMP2 gene transduction | [99] |
Bone | New Zealand white rabbit | Critical-sized segmental bone defects model (the ulna bone together with the periosteum) | 6 × 105 USCs/scaffold (Φ 5 × 5 mm) | Surface mineralized biphasic calcium phosphate (BCPs) ceramics scaffold | The composites were cultured in osteogenic differentiation media for 7 days | Promoted the formation of new bone and accelerated the maturation of new bone in ulna defects | Scaffold provided a favorable microenvironment that enabled USCs to adhere and proliferate, early (ALP, BMP2, and RUNX2) and late (OCN) osteogenic gene marker were continuously and significantly upregulated | [101] |
Bone | Sprague–Dawley rats | Skull defects | 1 × 105 USCs/hydrogel (5 mm in diameter) | Methacrylated solubilized decellularized cartilage (MeSDCC) hydrogel | USCs were infected with 10−6 mol/L BMP2 for 21 days | Increased bone formation, larger bone area | FAK plays a key role in regulating BMP2 enhanced osteogenic differentiation of USCs, the underlying mechanism might be the activation of AMPK and Wnt signaling pathways | [100] |
Bone | Sprague–Dawley rat | Glucocorticoid-induced osteonecrosis of the femoral head | 500 μg USCs-EVs/200 μL PBS (tail intervenous injection) | N/A | N/A | Prevention of early stage osteonecrosis, rescued angiogenesis impairment, reduced apoptosis of cells, prevented trabecular bone destruction and improved bone microarchitecture | TIMP1 and DMBT1, respectively, partly mediate the anti-apoptotic and pro-angiogenic effects of extracellular vesicles from USCs (USCs-EVs) | [43] |
Articular cartilage | N/A | N/A | BMSCs | N/A | Seeded on USCs-ECM for one passage | ECM deposited by USCs (USCs-ECM) could recharge senescent BMSCs toward chondrogenic differentiation | The Wnt11-mediated noncanonical signaling pathway might be responsible for USCs-ECM mediated BMSCs rejuvenation in terms of chondrogenic potential | [64] |
Articular cartilage | New Zealand white rabbit | Knee-joint cartilage defect model, 5 mm in diameter | 1 × 107 USCs/1 mL HA (injection into cartilage-defect knee joints) | 1% Hyaluronic acid solution (HA) | N/A | More neocartilage formation that matures over time, showed the expression of collagen type II and synthesized proteoglycans | USCs are able to differentiate into chondrocytes with characteristic deposition of aggrecan and collagen II | [46] |
Articular cartilage | N/A | N/A | 1 × 103 SDSCs/cm2 | UECM | N/A | Promoted proliferation and chondrogenic potential of SDSCs | Biophysical and biochemical cues (UECM is softer than others and contains different growth factors and collagen) | [65] |
N/A not applicable, BMSC bone marrow stromal cell, SDSC synovium-derived stem cells, β-TCP β-tricalcium phosphate, UECM ECM deposited by USCs, USCs urine-derived stem cells
Φ The diameter and height of 5 mm